Trastuzumab - PDFSEARCH.IO - Document Search Engine

Trastuzumab
Results: 445

#	Item
91	DRUG NAME, FORM(S), STRENGTH(S), SPONSOR, TYPE OF SUBMISSION DRUG TYPE AND USE LISTING REQUESTED BY SPONSOR / PURPOSE OF SUBMISSION Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 17:21:09 Orphan drugs Amines Organochlorides Piperazines Trastuzumab emtansine Trastuzumab Lapatinib Dasatinib Pertuzumab Chemistry Organic chemistry Organofluorides
92	A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cells Add to Reading List Source URL: www.nature.com Language: English - Date: 2015-03-12 09:35:45 Tyrosine kinase receptors Oncogenes Ribbon symbolism Cell signaling Epidermal growth factor receptor HER2/neu Trastuzumab ErbB Breast cancer Biology Cell biology Signal transduction
93	GERIATRIC THERAPEUTICS Editors: Michael Woodward, Director, Aged and Residential Care Services, Stephen Campbell, Consultant Geriatrician, Rohan Elliott, Clinical Pharmacist, Graeme Vernon, Drug Information Pharmacist, F Add to Reading List Source URL: jppr.shpa.org.au Language: English - Date: 2008-06-23 23:54:54 Ribbon symbolism Oncology Adjuvant therapy Breast cancer Tamoxifen Trastuzumab Exemestane Chemotherapy Oncotype DX Medicine Cancer treatments Aromatase inhibitors
94	Microsoft WordBreast Site Schema Stage 0 or 1-3 Add to Reading List Source URL: www.ucdenver.edu Language: English - Date: 2015-04-03 14:20:35 Ribbon symbolism Breast cancer Adjuvant therapy Eastern Cooperative Oncology Group HER2/neu Trastuzumab Pertuzumab Radiation Therapy Oncology Group Neoadjuvant therapy Medicine Cancer organizations Cancer treatments
95	Microsoft Word - Document1 Add to Reading List Source URL: www.ucdenver.edu Language: English - Date: 2015-04-03 14:19:00 Metastatic breast cancer Oncology HER2/neu Trastuzumab Eastern Cooperative Oncology Group Metastasis Pertuzumab Medicine Ribbon symbolism Breast cancer
96	MSAC Application 1175: Consultation Decision Analytical Protocol to guide the assessment of HER2 testing for access to lapatinib in advanced or metastatic breast cancer January 2012 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Tyrosine kinase receptors Ribbon symbolism Trastuzumab HER2/neu Aromatic amines Organochlorides Monoclonal antibodies Breast cancer Lapatinib Medicine Chemistry Biology
97	1175: Final Decision Analytic Protocol (DAP) to guide the assessment of HER2 testing for access to lapatinib in metastatic breast cancer May[removed]Table of Contents Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:56 Ribbon symbolism Trastuzumab HER2/neu Monoclonal antibodies Anatomical pathology Breast cancer Lapatinib Targeted therapy Personalized medicine Medicine Chemistry Biology
98	Public Summary Document Application No. 1230 – HER2 ISH testing for access to trastuzumab for neoadjuvant breast cancer Applicant: Roche Products Pty Ltd Australia Date of MSAC consideration: 2 August 2012 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:40 Trastuzumab HER2/neu Biology Breast cancer Management of cancer Predictive marker Breast cancer chemotherapy Ribbon symbolism Medicine Cancer treatments
99	Early breast cancer Initial PBS authority application and supporting information Purpose of this form Add to Reading List Source URL: www.humanservices.gov.au Language: English - Date: 2014-09-10 00:40:56 Trastuzumab Cancer treatments Breast cancer HER2/neu Pharmaceutical Benefits Scheme Medical prescription Adjuvant therapy Galena Biopharma Breast cancer treatment Medicine Health Ribbon symbolism
100	Stakeholder meeting statement Breast cancer treatment with anti-human epidermal growth factor receptor 2 (anti-HER2+) monoclonal antibody drugs A stakeholder meeting was held on 28 May 2014 to discuss how the treatment Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-03-13 00:39:15 Ribbon symbolism Cancer treatments Trastuzumab Lapatinib Breast cancer treatment Pertuzumab Breast cancer HER2/neu Management of cancer Chemistry Organic chemistry Medicine

UPDATE